GAVASSO, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.213
AS - Asia 564
EU - Europa 471
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
SA - Sud America 4
Totale 6.261
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.208
CN - Cina 261
SG - Singapore 238
IT - Italia 117
FI - Finlandia 94
SE - Svezia 71
DE - Germania 51
FR - Francia 34
VN - Vietnam 31
GB - Regno Unito 29
UA - Ucraina 29
IN - India 23
IE - Irlanda 10
NL - Olanda 9
RU - Federazione Russa 8
ES - Italia 5
HK - Hong Kong 5
CH - Svizzera 4
TW - Taiwan 4
AU - Australia 3
BR - Brasile 3
CA - Canada 3
EU - Europa 3
RO - Romania 3
BE - Belgio 2
CZ - Repubblica Ceca 2
MX - Messico 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
EE - Estonia 1
HR - Croazia 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SA - Arabia Saudita 1
Totale 6.261
Salva come PNG Salva come JPEG
Città #
Fairfield 924
Woodbridge 550
Chandler 501
Ann Arbor 375
Houston 362
Seattle 357
Ashburn 347
Cambridge 320
Wilmington 272
Singapore 190
Boardman 114
Jacksonville 105
Santa Clara 103
San Diego 94
Princeton 83
Beijing 81
Des Moines 63
Medford 54
Helsinki 51
Padova 41
Roxbury 39
Dong Ket 31
Nanjing 29
Shenyang 19
Falls Church 15
Hebei 15
Milan 12
New York 12
London 10
Nanchang 10
Guangzhou 9
Norwalk 8
Pune 8
Dublin 7
Jinan 7
Los Angeles 7
Kharkiv 6
Redwood City 6
Shanghai 6
Tianjin 6
Chicago 5
Hong Kong 5
Bologna 4
Dallas 4
Jiaxing 4
Ogden 4
Taipei 4
De Zilk 3
Detroit 3
Hangzhou 3
Kilburn 3
Kunming 3
Ningbo 3
Rome 3
Washington 3
Zhengzhou 3
Acton 2
Adligenswil 2
Changsha 2
Chongqing 2
Edinburgh 2
Falkenstein 2
Ferentino 2
Frankfurt am Main 2
Gurgaon 2
Hefei 2
Indiana 2
Las Vegas 2
Montreal 2
Munich 2
Newark 2
Piacenza 2
Rockville 2
Santa Ursula 2
Segovia 2
Shijiazhuang 2
Uberlândia 2
Adelaide 1
Adliswil 1
Atlanta 1
Bern 1
Borås 1
Brussels 1
Clifton 1
Cona 1
Dalian 1
Delhi 1
Dubbo 1
Esslingen am Neckar 1
Foggia 1
Granby 1
Groningen 1
Haikou 1
Iasi 1
Islington 1
Kiev 1
Lanzhou 1
Legnago 1
Madrid 1
Málaga 1
Totale 5.371
Salva come PNG Salva come JPEG
Nome #
Dynamics of circulating microparticles in obesity after weight loss 154
In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context 141
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 123
null 122
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 120
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 119
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study 119
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 119
Platelet factor V levels in moderate to severe congenital factor V deficiency. 118
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 117
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 114
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. 112
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 112
Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease 110
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 109
Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery 107
Effects of long-term administration of recombinant human protein C in xenografted primates. 107
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 107
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 105
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 105
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein i antibodies. A comparison with a homemade ELISA method 104
The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. 103
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. 103
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 102
Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation 101
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 101
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants 100
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. 100
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 99
Factor VIIa-antithrombin complexes in children with ischemic stroke. 99
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 98
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 97
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. 96
Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism 96
“In vitro” correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate 93
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 90
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism. 88
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 88
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 87
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 86
The haemostatic system in acromegaly: a single-centre case–control study 86
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 86
Similar hypercoagulable state and thrombosis risk in type Iand type III protein S-deficient individuals from families with mixed type I/IIIprotein S deficiency. 85
Thrombosis and thrombophilia in children: a systematic review. 85
Factor VIIa-antithrombin complexes plasma levels in cancer patients with and without thrombosis. 85
Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. 83
A protein S functional assay yields unsatisfactory results in patients with activated protein C resistance. 83
Identification of a novel frameshift mutation causing a premature stop codon in a young Nigerian man with type I antithrombin deficiency. 83
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. 81
Circulating microparticles in carriers of prothrombin G20210A mutation. 78
Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation. 77
Local prothrombotic state in portal venous system in cirrhosis 76
Effect on thrombin generation of the "in vitro" addition of low-dose LMWH to plasma of healthy pregnant and nonpregnant women. 75
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 75
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 72
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 72
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 71
Long term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: a study of 37 patients (2 homozygous and 35 heterozygous). 67
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 60
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 55
The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study 48
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 47
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 42
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 40
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 40
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 40
Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis" 37
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 36
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 30
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death 27
Whole blood thrombin generation shows a significant hypo-coagulable state in patients with decompensated cirrhosis 19
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 18
Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome. 18
Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation 15
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 14
Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome 12
Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study 11
Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis 9
Totale 6.309
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.761
article - articoli 24.194
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020752 0 0 0 0 0 85 114 146 160 118 76 53
2020/20211.029 33 92 85 123 94 56 39 91 110 103 105 98
2021/20221.122 56 108 159 36 53 106 57 98 62 44 109 234
2022/2023857 168 114 49 96 139 103 5 50 85 4 39 5
2023/2024379 16 70 45 48 22 45 19 10 13 20 29 42
2024/2025586 3 124 100 64 236 59 0 0 0 0 0 0
Totale 6.309